Ovintiv (NYSE:OVV - Get Free Report) had its target price upped by investment analysts at Royal Bank Of Canada from $85.00 to $90.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Royal Bank Of Canada's price target would indicate a potential upside of 37.22% from the stock's previous close.
Several other research firms have also weighed in on OVV. Stifel Nicolaus set a $92.00 target price on shares of Ovintiv and gave the company a "buy" rating in a research note on Wednesday, September 9th. Canadian Imperial Bank of Commerce increased their price objective on shares of Ovintiv from $65.00 to $75.00 and gave the stock a "neutral" rating in a research note on Friday. Wall Street Zen raised shares of Ovintiv from a "buy" rating to a "strong-buy" rating in a report on Saturday, October 3rd. Weiss Ratings upgraded Ovintiv from a "buy (b-)" rating to a "buy (b)" rating in a research note on Friday, October 2nd. Finally, Texas Capital upgraded Ovintiv to a "strong-buy" rating in a research note on Thursday, June 25th. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $70.32.
View Our Latest Analysis on Ovintiv
Ovintiv Price Performance
Shares of OVV opened at $65.59 on Tuesday. The firm has a market cap of $18.07 billion, a price-to-earnings ratio of 18.54 and a beta of 0.65. The stock has a 50 day moving average of $62.98 and a 200-day moving average of $59.32. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Ovintiv has a 52 week low of $35.47 and a 52 week high of $67.51.
Ovintiv (NYSE:OVV - Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $1.74 earnings per share for the quarter, missing analysts' consensus estimates of $1.94 by ($0.20). Ovintiv had a net margin of 9.43% and a return on equity of 14.84%. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.37 billion. As a group, analysts forecast that Ovintiv will post 7.29 EPS for the current year.
Insider Activity at Ovintiv
In related news, EVP Rachel Moore sold 7,753 shares of the stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $63.32, for a total value of $490,919.96. Following the sale, the executive vice president owned 72,530 shares of the company's stock, valued at $4,592,599.60. This trade represents a 9.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.85% of the company's stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Man Group plc acquired a new stake in shares of Ovintiv during the 2nd quarter valued at $936,000. Bank of America Corp DE bought a new stake in shares of Ovintiv during the 2nd quarter worth $79,475,000. Corient Private Wealth LP acquired a new position in shares of Ovintiv in the 2nd quarter worth $9,481,000. PensionDanmark Pensionsforsikringsaktieselskab acquired a new position in shares of Ovintiv in the 2nd quarter worth $4,738,000. Finally, Core Capital Management & Research inc. acquired a new position in shares of Ovintiv in the 2nd quarter worth $4,716,000. 83.81% of the stock is owned by institutional investors and hedge funds.
Key Stories Impacting Ovintiv
Here are the key news stories impacting Ovintiv this week:
- Positive Sentiment: Zacks Research raised multiple EPS forecasts: Estimates increased for Q4 2026 to $1.52 from $1.49, FY2026 to $6.73 from $6.71, and FY2027 to $5.49 from $5.24. Forecasts also rose for each reported quarter from Q1 2027 through Q4 2027, as well as Q2 2028 to $2.10 from $2.01. The revisions indicate improving expectations for Ovintiv’s future profitability, although Zacks retained its Hold rating. Zacks Research article on Ovintiv estimates
- Positive Sentiment: Operating momentum remains a key catalyst: Zacks noted that Ovintiv has outperformed its subindustry over the past three months, supported by higher oil production, strong free cash flow and a deep drilling inventory. These factors could help sustain growth and shareholder returns. Ovintiv stock performance and outlook
- Neutral Sentiment: UBS expects a positive company update, but its outlook acknowledges midstream-related headwinds. This suggests Ovintiv’s operating performance may remain solid while infrastructure or transportation issues could temper the near-term upside. UBS outlook for Ovintiv
- Negative Sentiment: Natural-gas weakness remains a risk. Despite stronger oil output and free cash flow, Zacks highlighted natural-gas headwinds, which could pressure revenue and earnings if prices remain weak. The current full-year consensus of $7.29 EPS also remains above Zacks’ $6.73 FY2026 estimate, leaving room for earnings expectations to disappoint. Zacks risks for Ovintiv
About Ovintiv
(
Get Free Report)
Ovintiv Inc NYSE: OVV is an energy company engaged in the exploration, development, production and operation of oil and natural gas properties. Its production includes crude oil, condensate, plant condensate, natural gas liquids and natural gas.
The company's operations are concentrated in North America, with core assets in the Permian Basin, Uinta Basin and Anadarko Basin in the United States, as well as the Montney region in western Canada. Ovintiv also owns and operates related processing, gathering and other midstream infrastructure that supports the production and transportation of its energy products.
Ovintiv was formerly known as Encana Corporation and adopted its current name in 2020.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ovintiv, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.
While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.